Silver Book Fact

U.S. spending on cancer treatment has risen greatly over time, from $13.1 billion in 1980 to $72.1 billion in 2004. 

Phillipson, Thomas, Michael Eber, Darius N. Lakdawalla, Mitra Corral, Rena Conti, and Dana P. Goldman. An Analysis Of Whether Higher Health Care Spending In The United States Versus Europe Is ‘Worth It’ In The Case of Cancer. Health Affairs. 2012; 31(4): 667-675

Reference

Title
An Analysis Of Whether Higher Health Care Spending In The United States Versus Europe Is ‘Worth It’ In The Case of Cancer
Publication
Health Affairs
Publisher
Project HOPE
Publication Date
2012
Authors
Phillipson, Thomas, Michael Eber, Darius N. Lakdawalla, Mitra Corral, Rena Conti, and Dana P. Goldman
Volume & Issue
Volume 31, Issue 4
Pages
667-675

Categories

  • Cost of Disease
  • Economic Burden

Related Facts

  • Colorectal cancer is the third most common cancer and third leading cause of cancer death in the U.S. Approximately 148,810 new cases and 49,960 deaths were expected in 2008.  
  • Cost of Cancer Care by Phase of Care, All Sites, All Ages, Male and Female, in 2010 Dollars  
  • In 2002, cancer patients made 2.1 million visits to hospital outpatient departments.  
  • Three million cancer patients remain active in the workplace during their treatment, and incur 33 million days of disability each year.  
  • The National Cancer Institute estimated that in January 2001, there were approximately 9.8 million Americans with a history of cancer.